self pay semaglutide Savings Offer Program for patients taking Wegovy (semaglutide) injection 2.4 mg Novo Nordisk launches introductory self-pay

PCA plot was created using PCA tools v.2.14.0 package [37]

Genetic testing is available as a $99 add-on after your first month of semaglutide therapy, allowing your provider to confirm the regimen aligns with your peptide genetics

How It Works: Wegovy is a GLP-1 receptor agonist that mimics a hormone in your body responsible for regulating appetite

Choose phentermine if: You need rapid, short-term weight loss (10-20 pounds) Budget is a primary constraint You have no cardiovascular concerns You are not taking medications that interact with stimulants You have a solid plan for maintaining results after stopping You prefer pills over injections and cannot use oral semaglutide Choose semaglutide if: You have substantial weight to lose (30+ pounds) You need long-term appetite management You have type 2 diabetes or prediabetes You have cardiovascular risk factors Previous weight loss attempts have failed You want the option to continue treatment as long as needed You value the metabolic benefits beyond weight loss alone For most people with significant weight loss goals and no budget constraints, semaglutide delivers superior outcomes across nearly every metric

What is NAD+ Injection

Plans will need to be prepared to manage this drug as we can expect tremendous growth, especially due to off-label utilization and shortages of Wegovy and Ozempic